drugset / Trial / NCT04058587
A Phase I Trial of Simmitinib in Advanced Solid Tumors
Phase 1
Unknown
50 enrolled
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Shanghai Runshi Pharmaceutical Technology Co., Ltd · collab
NaSingle-groupOpen-labelTreatment
Summary
This is an open label, multi-center, phase I study of oral Simmitinib in subjects with advanced solid tumors including gastric cancer.
Timeline
- Start
- 2020-06-08
- Primary completion
- 2023-01-31
- Completion
- 2023-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Simmitinib | Small molecule | 1 mg | Oral |